A Novel Scoring System for Patients with Recurrence of Hepatocellular Carcinoma After Undergoing Minimal Invasive Therapies

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6 ):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Heimbach JK. Overview of the updated AASLD guidelines for the management of HCC. Gastroenterol Hepatol. 2017;13(12 ):751–753.
   Google Scholar
• Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1 ):358–380. doi:10.1002/hep.2908628130846
   PubMed Web of Science ®Google Scholar
• Benson AB 3rd, D’Angelica MI, Abbott DE, et al. NCCN guidelines insights: hepatobiliary cancers, version 1. 2017. J Natl Compr Cancer Netw. 2017;15(5 ):563–573. doi:10.6004/jnccn.2017.0059
   PubMed Web of Science ®Google Scholar
• Borie F, Bouvier A-M, Herrero A, et al. Treatment and prognosis of hepatocellular carcinoma: a population based study in France. J Surg Oncol. 2008;98(7 ):505–509. doi:10.1002/jso.v98:718932235
   PubMed Web of Science ®Google Scholar
• Kim AR, Park E, Kwon SY, et al. Efficacy and safety of combined radiofrequency ablation with transarterial chemoembolization in patients with barcelona clinic liver cancer stage a hepatocellular carcinoma ineligible for curative treatment. Korean J Gastroenterol. 2019;73(3 ):167–176. doi:10.4166/kjg.2019.73.3.16731013560
   PubMedGoogle Scholar
• Morimoto M, Numata K, Kondou M, Nozaki A, Morita S, Tanaka K. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer. 2010;116(23 ):5452–5460. doi:10.1002/cncr.2531420672352
   PubMedGoogle Scholar
• Ahrar K, Newman RA, Pang J, Vijjeswarapu MK, Wallace MJ, Wright KC. 2004 Dr. Gary J. Becker Young investigator award: relative thermosensitivity of cytotoxic drugs used in transcatheter arterial chemoembolization. J Vasc Interv Radiol. 2004;15:901–905. doi:10.1097/01.RVI.0000136829.36643.ED15361556
   PubMed Web of Science ®Google Scholar
• Iezzi R, Pompili M, La Torre MF, et al. Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma. Dig Liver Dis. 2015;47:242–248. doi:10.1016/j.dld.2014.12.00725577299
   PubMedGoogle Scholar
• Huang G, Jiang H, Lin Y, et al. Prognostic value of plasma fibrinogen in hepatocellular carcinoma: a meta-analysis. Cancer Manag Res. 2018;29;10(Oct ):5027–5041. doi:10.2147/CMAR.S175780
   Google Scholar
• Chen K, Zhan MX, Hu BS, et al. Combination of the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio as a useful predictor for recurrence following radiofrequency ablation of hepatocellular carcinoma. Oncol Lett. 2018;15(1 ):315–323. doi:10.3892/ol.2017.729129285194
   PubMed Web of Science ®Google Scholar
• Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1 ):358–380. doi:10.1002/hep.2908628130846
   PubMed Web of Science ®Google Scholar
• Chung HA, Kim JH, Hwang Y, et al. Noninvasive fibrosis marker can predict recurrence of hepatocellular carcinoma after radiofrequency ablation. Saudi J Gastroenterol. 2016;22(1 ):57–63. doi:10.4103/1319-3767.17376026831608
   PubMed Web of Science ®Google Scholar
• Seo JY, Kim W, Kwon JH, et al. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation. Liver Int. 2013;33(6 ):884–893. doi:10.1111/liv.1213223461618
   PubMed Web of Science ®Google Scholar
• Sheng RF, Zeng MS, Ren ZG, et al. Intrahepatic distant recurrence following complete radiofrequency ablation of small hepatocellular carcinoma: risk factors and early MRI evaluation. Hepatobiliary Pancreat Dis Int. 2015;14(6 ):603–612. doi:10.1016/S1499-3872(15)60390-326663008
   PubMed Web of Science ®Google Scholar
• Oh IS, Sinn DH, Kang TW, et al. Liver function assessment using albumin-bilirubin grade for patients with very early-stage hepatocellular carcinoma treated with radiofrequency ablation. Dig Dis Sci. 2017;62(11 ):3235–3242. doi:10.1007/s10620-017-4775-828983724
   PubMed Web of Science ®Google Scholar
• Tateishi R, Shiina S, Yoshida H, et al. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Hepatology. 2006;44(6 ):1518–1527. doi:10.1002/(ISSN)1527-335017133456
   PubMed Web of Science ®Google Scholar
• Lee S, Rhim H, Kim YS, et al. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma. Liver Int. 2016;36(4 ):580–587. doi:10.1111/liv.1299126503910
   PubMed Web of Science ®Google Scholar
• Douhara A, Namisaki T, Moriya K, et al. Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolization. Oncol Lett. 2017;14(3 ):3028–3034. doi:10.3892/ol.2017.648928927051
   PubMed Web of Science ®Google Scholar
• Chu MO, Shen CH, Chang TS, et al. Pretreatment inflammation-based markers predict survival outcomes in patients with early stage hepatocellular carcinoma after radiofrequency ablation. Sci Rep. 2018;8(1 ):16611. doi:10.1038/s41598-018-34543-z30413724
   PubMed Web of Science ®Google Scholar
• Hu J, Wang NY, Yang YF, et al. Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma. BMC Gastroenterol. 2018;18(1 ):186. doi:10.1186/s12876-018-0908-630545306
   PubMedGoogle Scholar
• Chinnaratha MA, Sathananthan D, Pateria P, et al. High local recurrence of early-stage hepatocellular carcinoma after percutaneous thermal ablation in routine clinical practice. Eur J Gastroenterol Hepatol. 2015;27(3 ):349–354. doi:10.1097/MEG.000000000000027025563141
   PubMed Web of Science ®Google Scholar
• Lee S, Kang TW, Song KD, et al. Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg. 2019.
   Web of Science ®Google Scholar
• Ao JP, Meng J, Zhu L, et al. Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion. Mol Oncol. 2012;6(5 ):507–515. doi:10.1016/j.molonc.2012.06.00522819717
   PubMed Web of Science ®Google Scholar
• Du B, Wang SY, Shi XF, et al. The effect of 2-methoxyestradiol liposome on growth inhibition, angiogenesis and expression of VEGF and Ki67 in mice bearing H22 hepatocellular carcinoma. Tumori. 2011;97(5 ):660–665. doi:10.1177/03008916110970052022158500
   PubMed Web of Science ®Google Scholar
• Yang SL, Liu P, Yang S, et al. Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma. Br J Surg. 2016;103(6 ):716–724. doi:10.1002/bjs.1009326996727
   PubMed Web of Science ®Google Scholar
• Gomaa AI, AI-Khatib A, Abdel-Razek W, et al. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona clinic liver cancer staging. World J Gastroenterol. 2015;21(18 ):5654–5662. doi:10.3748/wjg.v21.i18.565425987792
   PubMed Web of Science ®Google Scholar
• Garcia MG, Bayo J, Bolontrade MF, et al. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo. Mol Pharm. 2011;8(5 ):1538–1548. doi:10.1021/mp200137c21770423
   PubMedGoogle Scholar
• Levitt DG, Levitt MD. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med. 2016;9:229–255. doi:10.2147/IJGM.S10281927486341
   PubMed Web of Science ®Google Scholar
• Shenkin A. Serum prealbumin: is it a marker of nutritional status or of risk of malnutrition? Clin Chem. 2006;52(12 ):2177–2179. doi:10.1373/clinchem.2006.07741217138848
   PubMed Web of Science ®Google Scholar